Issue 7, 2016

Synthesis of new α-aminophosphonate derivatives incorporating benzimidazole, theophylline and adenine nucleobases using l-cysteine functionalized magnetic nanoparticles (LCMNP) as magnetic reusable catalyst: evaluation of their anticancer properties

Abstract

A new class of structurally diverse α-aminophosphonate derivatives containing benzimidazole, theophylline and adenine heterocycles were synthesized using a simple and efficient strategy. This class of α-aminophosphonates was synthesized using the reaction of synthetic aldehydes containing nucleobases, amines and diethyl phosphonate using L-cysteine functionalized magnetic nanoparticles (LCMNP) as catalyst. The aldehyde derivatives containing benzimidazole, theophylline and adenine nucleobases were synthesized using the reaction of a bromo-substituted aldehyde derived from isovanillin and 4-hydroxy benzaldehyde. The LCMNP catalyst was found to be an efficient magnetic reusable catalyst for synthesis of this class of α-aminophosphonates under mild and clean conditions. This method is introduced as a suitable approach for the synthesis of new α-aminophosphonate derivatives containing nucleobases which have potential biological activity. When the anticancer properties of a selected group of these synthetic ligands were evaluated, they indicated poor activity compared to cisplatin against the Jurkat cancer cell line.

Graphical abstract: Synthesis of new α-aminophosphonate derivatives incorporating benzimidazole, theophylline and adenine nucleobases using l-cysteine functionalized magnetic nanoparticles (LCMNP) as magnetic reusable catalyst: evaluation of their anticancer properties

Supplementary files

Article information

Article type
Paper
Submitted
15 Oct 2015
Accepted
04 Jan 2016
First published
08 Jan 2016

RSC Adv., 2016,6, 5915-5924

Synthesis of new α-aminophosphonate derivatives incorporating benzimidazole, theophylline and adenine nucleobases using L-cysteine functionalized magnetic nanoparticles (LCMNP) as magnetic reusable catalyst: evaluation of their anticancer properties

F. Bahrami, F. Panahi, F. Daneshgar, R. Yousefi, M. B. Shahsavani and A. Khalafi-Nezhad, RSC Adv., 2016, 6, 5915 DOI: 10.1039/C5RA21419J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements